The role of inflammation in epilepsy

Öz

Epilepsy is one of the most common diseases worldwide and in our country. Data on the relationship between inflammatory mediators and the production of immune cells and the recurrence of epileptic seizures are becoming more evident in the light of experimental and clinical studies. Therefore, the relationship between epilepsy and inflammation is of interest.  In this review, the relationship between epilepsy and inflammation is investigated.

Anahtar Kelimeler

• Inflammation,epilepsi,sitokin,kemokin

Epilepside inflamasyonun rolü

Öz

Epilepsi, dünya çapında ve ülkemizde oldukça yaygın görülen hastalıklardan biridir. İnflamatuvar mediatörler ve immün hücrelerin üretilmesi ile epileptik nöbetlerin tekrarı arasındaki ilişki hakkında gün geçtikçe deneysel ve klinik çalışmaların ışığında birbirini destekleyen veriler ortaya çıkmaktadır. Bundan dolayı epilepsi ve inflamasyon ilişkisi ilgi çekmektedir. Bu derlemede epilepsi ile inflamasyon ilişkisi incelenmiştir.

Anahtar Kelimeler

• İnflamasyon,Epilepsi,Sitokin,Kemokin

Kaynakça

1. 1. Devinsky O. Effects of seizures on autonomic and cardiovascular function. Epilepsy Currents. 2004;4(2):43–46.
2. 2. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshé SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014;55:475–482.
3. 3. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530.
4. 4. Wiebe S, Blume WT, Girvin JP, Eliasziw MA. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 2001;345(5):311-318.
5. 5. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011;7(1):31-40.
6. 6. Bambal G, Cakıl D, Ekici F. Epilepsi Oluşum Mekanizmaları Konuralp Tıp Dergisi. 2011;3(3) :42-45
7. 7. Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr. 2017;29(1):1-16
8. 8. Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J. 2008;49(1):1 -18.

9. 9. Jung KH, Chu K, Lee ST, Kim JH, Kang KM, Song EC, Kim SJ, Park HK, Kim M, Lee SK, Roh JK. Region-specific plasticity in the epileptic rat brain: a hippocampal and extrahippocampal analysis. Epilepsia. 2009;50(3):537-549.
10. 10. Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F, Knake S, Oertel WH, Hamer HM. Cytokines and epilepsy. Seizure 2011;20(3):249-256.
11. 11. Scorza CA, Marques MJG, Gomes da Silva S, Naffah-Mazzacoratti MDG, Scorza FA, Cavalheiro EA. Status epilepticus does not induce acute brain inflammatory response in the Amazon rodent Proechimys, an animal model resistant to epileptogenesis. Neurosci. Lett. 2018;668:169-173.
12. 12. Ichiyama T, Nishikawa M, Yoshitomi T, Hayashi T, Furukawa S. Tumor necrosis factor-a, interleukin-l, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures comparison with acute encephalitis/encephalopathy. Neurology. 1998;50(2):407–411.
13. 13. Rana A, Musto AE. The role of inflammation in the development of epilepsy. Journal of neuroinflammation. 2018;15:144.
14. 14. Postnikova T, Zubareva O, Kovalenko A, Kim K, Magazanik L, Zaitsev A. Status epilepticus impairs synaptic plasticity in rat hippocampus and is followed by changes in expression of NMDA receptors. Biochem Mosc. 2017;82(3):282–90
15. 15. Han T, Qin Y, Mou C, Wang M, Jiang M, Liu B. Seizure induced synaptic plasticity alteration in hippocampus is mediated by IL-1ß receptor through PI3K/Akt pathway. Am J. Transl. Res. 2016;8(10):4499-4509.
16. 16. Vezzani A, & Baram TZ. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy currents. 2007;7(2):45-50.
17. 17. Hirano T, Taga T, Yamasaki K, Matsuda T, Tang B, Muraguchi A, Horii Y, Suematsu S, Hirata Y, Yawata H, et al. A multifunctional cytokine (IL-6/BSF-2) and its receptor. Int. Arch Allergy Appl. Immunol. 1989;88(1-2):29-33.
18. 18. Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 1992;31(2):123-130.
19. 19. Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 onIL-6 responses. J. Immunol. 1998;161(11):6347-6355.
20. 20. De Luca G, Di Giorgio RM, Macaione S, Calpona PR, Costantino S, Di Paola ED, De Sarro A, Ciliberto G, De Sarro G. Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol. Biochem. Behav. 2004;78(1):75-81.
21. 21. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-αlpha. Nature. 2006;440(7087):1054-1059.
22. 22. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front. Neuroendocrino.l 2012;33(1):116-25.
23. 23. Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005;25(12):3219-28.
24. 24. Loetscher H, Steinmetz M, Lesslauer W. Tumor necrosis factor: receptors and inhibitors. Cancer Cells. 1991;3(6):221-6.
25. 25. Mukai Y, Shibata H, Nakamura T, Yoshioka Y, Abe Y, Nomura T, Taniai M, Ohta T, Ikemizu S, Nakagawa S, Tsunoda S, Kamada H, Yamagata Y, Tsutsumi Y. Structure–function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant. J. Mol. Biol. 2009;385(4):1221-1229.
26. 26. Natoli G, Costanzo A, Moretti F, Fulco M, Balsano C, Levrero M. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem. 1997;272(42):26079-26082.
27. 27. Godlevsky LS, Shandra AA, Oleinik AA, Vastyanov RS, Kostyushov VV, Timchishin OL. TNF-alpha in cerebral cortex and cerebellum is affected by amygdalar kindling but not by stimulation of cerebellum. Pol. J. Pharmacol .2002;54(6):655-660.
28. 28. Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG, Vezzani A. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol. 2005;57(6):804-812.
29. 29. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneousinflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad Sci. 1995;92(24):11294-11298.
30. 30. Ichiyama T, Suenaga N, Kajimoto M, Tohyama J, Isumi H, Kubota M, Mori M, Furukawa S. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain. Dev. 2008;30(1):47-52.
31. 31. Bozzi Y, Caleo M. Epilepsy, Seizures, and Inflammation: Role of the C-C Motif Ligand 2 Chemokine. DNA Cell Biol. 2016;35(6):257-260.
32. 32. Fabene PF, Bramanti P, Constantin G. The emerging role for chemokines in epilepsy. J. Neuroimmunol. 2010;224(1-2):22-27.
33. 33. Li R, Ma L, Huang H, Ou S, Yuan J, Xu T, Yu X, Liu X, Yang J, Chen Y, Peng X. Altered expression of CXCL13 and CXCR5 inintractable temporal lobe epilepsy patients and pilocarpine-induced epileptic rats. Neurochem. Res. 2017;42(2):526-540.
34. 34. Viviani B, Gardoni F, Marinovich M. Cytokines and Neuronal Ion Channels in Health and Disease. Int. Rev. Neurobiol. 2007;82:247-63.
35. 35. Rantala H, Tarkka R, Uhari M. Systematic review of the role of prostaglandins and their synthetase inhibitors with respect to febrile seizures. Epilepsy. Res. 2001;46(3):251-257.
36. 36. Kaushik MK, Aritake K, Kamauchi S, Hayaishi O, Huang ZL, Lazarus M, Urade Y. Prostaglandin D(2) is crucial for seizure suppression and postictal sleep. Exp. Neurol. 2014;253:82-90.
37. 37. Takemiya T, Matsumura K, Sugiura H, Maehara M, Yasuda S, Uematsu S, Akira S, Yamagata K. Endothelial microsomal prostaglandin E synthase-1 exacerbates neuronal loss induced by kainate. J. Neurosci Res. 2010;88(2):381-390.
38. 38. Shimada T, Takemiya T, Sugiura H, Yamagata K. Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators. Inflamm. 2014;2014:901-902.
39. 39. Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends. Neurosci. 2014;37(2):55-65.
40. 40. Dey A, Kang X, Qiu J, Du Y, Jiang J. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside. Trends Pharmacol. Sci. 2016;37(6):463-484.